Results 131 to 140 of about 32,071 (158)

Remdesivir associated with reduced mortality in hospitalized COVID-19 patients: treatment effectiveness using real-world data and natural language processing. [PDF]

BMC Infect Dis
Arribas López JR, Ruiz Seco MP, Fanjul F, Díaz Pollán B, González Ruano Pérez P, Ferre Beltrán A, De Miguel Buckley R, Portillo Horcajada L, De Álvaro Pérez C, Barroso Santos Carvalho PJ, Savana Research Group, Riera Jaume M.   +11 more
europepmc   +1 more source

Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment. [PDF]

Clin Transl Sci
Regan S, Humeniuk R, Caro L, Abdelghany M, Davies S, Baysa A, Shen G, Hyland RH, Kim A.   +8 more
europepmc   +1 more source

The impact of remdesivir on SARS-CoV-2 evolution in vivo. [PDF]

JCI Insight
Ling-Hu T, Simons LM, Rios-Guzman E, Carvalho AM, Agnes MFR, Alisoltanidehkordi A, Ozer EA, Lorenzo-Redondo R, Hultquist JF.   +8 more
europepmc   +1 more source

Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19. [PDF]

Clin Infect Dis
Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Berry M, Oppelt T, Okulicz JF, Amin AN, Welte T, Sax PE, Kalil AC.   +10 more
europepmc   +1 more source

Case report: Persistent COVID-19 in a patient with B cell lymphoma refractory to antiviral treatment due to resistance to Remdesivir. [PDF]

IDCases
de Assumpção LECC, Romeo BGP, Guerra JCC, Camargo LFA, Nagaoka MA, Amgarten DE, Dorlass EG, Petroni RC, Cardoso ACA, Ruiz RM, Bittante CD, Teich VD, Pinho JRR, Doi AM.   +13 more
europepmc   +1 more source

Effectiveness of early intervention and combination treatment with monoclonal antibodies and antivirals in oncohematological patients with SARS-CoV-2: a retrospective experience. [PDF]

Front Immunol
Di Bari S, Izzo F, Bresciani L, Mancarella G, Garattini S, Gasperin A, Di Trento D, Grimaldi A, Parente A, Marocco R, Carraro A, Kertusha B, Tieghi T, Del Borgo C, Vita S, Guardiani M, Pasquazzi C, Spagnoli A, Alunni Fegatelli D, Lichtner M.   +19 more
europepmc   +1 more source

Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis. [PDF]

J Med Virol
Fourgeaud J, Turlure P, Dupont M, Veyrenche N, Busquet C, Alain S, Leruez-Ville M, Dheilly NM, Frange P.   +8 more
europepmc   +1 more source

Antivirals in COVID-19: A Focus on Pediatric Cardiac Patients. [PDF]

Can J Infect Dis Med Microbiol
Safi D, Khouri F, Zareef R, Arabi M.
europepmc   +1 more source

Translational Success and Pharmacoeconomic Lessons of Pandemic-Driven Drug Repurposing. [PDF]

Cureus
Elechi KW, Adeoye AF, Olaniyi AO, Akanbi OO, Olumeko I, Udensi CG, Kolapo TJ, Barrah VU.   +7 more
europepmc   +1 more source

QSPR modeling of some COVID-19 drugs using neighborhood eccentricity-based topological indices: A comparative analysis. [PDF]

PLoS One
Kara Y, Özkan YS, Ullah A, Hamed YS, Belay MB.   +4 more
europepmc   +1 more source